Inogen (INGN) Acquisitions (2017)
Inogen (INGN) posted quarterly Acquisitions of $47000.0 for Q4 2017, up 840.0% quarter-over-quarter from $5000.0 in Q3 2017.
Inogen (INGN) Acquisitions (2017) Analysis & Trends
Inogen (INGN) has reported Acquisitions for 1 consecutive years, with $47000.0 the latest figure, recorded in Q4 2017.
- In Q4 2017, Acquisitions changed N/A year-over-year to $47000.0; the TTM figure through Dec 2023 stood at $52000.0 (changed N/A YoY), while the FY2023 annual figure was $29.6 million, changed N/A from the prior year.
- Acquisitions rose to $47000.0 in Q4 2017 per INGN's latest filing, from $5000.0 in the prior quarter.
- Across five years, Acquisitions topped out at $47000.0 in Q4 2017 and bottomed at $5000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 437.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -4.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3.49 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 47,000.00 |
| Sep 30, 2017 | 5,000.00 |